{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:55:47Z","timestamp":1773658547283,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1765,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1111\/j.1348-0421.2010.00262.x","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T16:08:41Z","timestamp":1283357321000},"page":"673-683","source":"Crossref","is-referenced-by-count":11,"title":["Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus"],"prefix":"10.1111","volume":"54","author":[{"given":"Takashi","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kantou","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pakamatz","family":"Khawplod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nishizono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,2]]},"reference":[{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB2|cit2","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB3|cit3","volume-title":"Laboratory Techniques in Rabies","author":"Meslin","year":"1996"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM199101243240401","article-title":"Unexplained rabies in three immigrants in the United States. A virologic investigation","volume":"324","author":"Smith","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB5|cit5","first-page":"1","article-title":"WHO expert consultation on rabies","volume":"931","author":"WHO","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB6|cit6","first-page":"1","article-title":"Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB7|cit7","first-page":"48","article-title":"Rabies immune globulin (human) in the prevention of rabies","volume":"33","author":"Cabasso","year":"1976","journal-title":"Am J Hosp Pharm"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB8|cit8","first-page":"731","article-title":"Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin","volume":"67","author":"Wilde","year":"1989","journal-title":"Bull World Health Organ"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice. Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(89)90003-0","article-title":"Adverse effects of equine rabies immune globulin","volume":"7","author":"Wilde","year":"1989","journal-title":"Vaccine"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.vaccine.2004.09.013","article-title":"Adverse reactions to human rabies immune globulin manufactured by the Thai Red Cross Society","volume":"23","author":"Suwansrinon","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.trstmh.2006.04.009","article-title":"Sex- and age-related differences in rabies immunoglobulin hypersensitivity","volume":"101","author":"Suwansrinon","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in post-exposure treatment of rabies","volume":"84","author":"Schumacher","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB14|cit14","unstructured":"WHO 2002 WHO consultation on a rabies monoclonal antibody cocktail for rabies post exposure treatment WHO http:\/\/www.who.int\/entity\/rabies\/vaccines\/en\/mabs_final_report.pdf"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","article-title":"The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure","volume":"235","author":"Champion","year":"2000","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","article-title":"Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence","volume":"62","author":"Prehaud","year":"1988","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","article-title":"Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies","volume":"64","author":"Lafon","year":"1983","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/JVI.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-70-2-291","article-title":"Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein","volume":"70","author":"Bunschoten","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1099\/0022-1317-71-8-1689","article-title":"Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein","volume":"71","author":"Lafon","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.171.1.19","article-title":"Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus","volume":"171","author":"Ueki","year":"1990","journal-title":"J Exp Med"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","article-title":"Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis","volume":"19","author":"Hanlon","year":"2001","journal-title":"Vaccine"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates","volume":"25","author":"Sloan","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/eji.200526134","article-title":"The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries","volume":"35","author":"Kramer","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for post-exposure prophylaxis of rabies","volume":"188","author":"Prosniak","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","author":"Goudsmit","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","article-title":"A human monoclonal antibody cocktail as a novel component of rabies post-exposure prophylaxis","volume":"58","author":"De Kruif","year":"2007","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","article-title":"Biological characterization of human monoclonal antibodies to rabies virus","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"Marissen","year":"2005","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1128\/JVI.66.8.5133-5136.1992","article-title":"Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes","volume":"66","author":"Swaminathan","year":"1992","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jviromet.2009.05.018","article-title":"Development and evaluation of a rapid neutralizing antibody test for rabies","volume":"161","author":"Shiota","year":"2009","journal-title":"J Virol Methods"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB37|cit37","first-page":"1","article-title":"WHO Expert Committee on Rabies","volume":"824","author":"WHO","year":"1992","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1708-8305.2007.00120.x","article-title":"Immunogenicity study of abbreviated rabies pre-exposure vaccination schedules","volume":"14","author":"Khawplod","year":"2007","journal-title":"J Travel Med"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1348-0421.2005.tb03735.x","article-title":"Construction of human Fab library and isolation of monoclonal Fabs with rabies virus-neutralizing ability","volume":"49","author":"Ando","year":"2005","journal-title":"Microbiol Immunol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB40|cit40","first-page":"307","volume-title":"Antibody Engineering","volume":"1","author":"Kontermann","year":"2010"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1348-0421.2007.tb03948.x","article-title":"Construction of human Fab (gamma1\/kappa) library and identification of human monoclonal Fab possessing neutralizing potency against Japanese encephalitis virus","volume":"51","author":"Arakawa","year":"2007","journal-title":"Microbiol Immunol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1128\/IAI.69.11.6846-6852.2001","article-title":"Comparison of genomic structures and antigenic reactivities of orthologous 29-kilodalton outer membrane proteins of Helicobacter pylori","volume":"69","author":"Sumie","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JVI.65.1.541-545.1991","article-title":"Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line","volume":"65","author":"Gras","year":"1991","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/aid.1993.9.619","article-title":"Complement-dependent virolysis of HIV-1 with monoclonal antibody NM-01","volume":"9","author":"Nakamura","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.meegid.2005.06.002","article-title":"Genetic analysis of dog rabies viruses circulating in Bangkok","volume":"6","author":"Khawplod","year":"2006","journal-title":"Infect Genet Evol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/bp025574h","article-title":"High-level expression of recombinant IgG in the human cell line per.c6","volume":"19","author":"Jones","year":"2003","journal-title":"Biotechnol Prog"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J Virol"},{"key":"10.1111\/j.1348-0421.2010.00262.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virusres.2005.08.004","article-title":"Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice","volume":"115","author":"Takayama-Ito","year":"2006","journal-title":"Virus Res"}],"container-title":["Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1348-0421.2010.00262.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1348-0421.2010.00262.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T13:32:07Z","timestamp":1625405527000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1348-0421.2010.00262.x"}},"subtitle":["Human mAb against rabies virus"],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1348-0421.2010.00262.x","relation":{},"ISSN":["0385-5600"],"issn-type":[{"value":"0385-5600","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}